Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels

Stopped Unable to align the study questions with a complementary trial

Conditions

• Crohn's Disease
• Ulcerative Colitis

Sponsor

University of Western Ontario, Canada